Stay updated with breaking news from Zymeworks Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NEW YORK, May 19, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Zymeworks Inc. (NASDAQ:ZYME), Regeneron
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zymeworks Inc. ("Zymeworks" or the "Company") (NASDAQ: ZYME). Such investors...
NEW YORK, May 6, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zymeworks Inc. . Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com...
Has released an update. Zymeworks Inc., a clinical-stage biotech company, has announced a robust financial position with a cash ru...
How have advancements in antibody-drug conjugates expanded treatment options for different types of cancer? The design of ADCs has advanced considerably since initial efforts in the 1980's, when...